New combo therapy aims to wipe out aggressive breast cancer before surgery
NCT ID NCT06682195
First seen Jan 14, 2026 · Last updated May 10, 2026 · Updated 16 times
Summary
This study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy before surgery can completely eliminate triple-negative breast cancer in 35 women. Participants will receive the drug combination, then have surgery, and be followed for side effects and cancer recurrence. The goal is to see if this approach leads to a higher rate of no cancer remaining at the time of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin Medical University Cancer Hospital
NOT_YET_RECRUITINGHarbin, China
Contact
-
Jinhua Municipal Central Hospital
RECRUITINGJinhua, China
Contact
-
Nanchang People's Hospital
NOT_YET_RECRUITINGNanchang, Jiangxi, China
Contact
-
Nantong First People's Hospital
RECRUITINGNantong, China
Contact
-
Shanxi Provincial Cancer Hospital
NOT_YET_RECRUITINGShanxi, China
Contact
-
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
RECRUITINGHangzhou, China
Contact
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, China
Contact
-
The First Affiliated Hospital of Zhejiang University
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, China
Contact
-
The Second Affiliated Hospital of Xi'an Jiaotong University
NOT_YET_RECRUITINGXi'an, China
Contact
-
Xinjiang Medical University Affiliated Cancer Hospital
NOT_YET_RECRUITINGXinjiang, China
Contact
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, China
Contact
-
Zhongshan Hospital, Fudan University
RECRUITINGShanghai, China
Contact
Conditions
Explore the condition pages connected to this study.